 | • レポートコード：MRC2301A040 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、259ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：医療 |
| Single User（1名利用、印刷可） | ￥742,350 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,492,350 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社の本調査レポートでは、2021年に405.6億ドルであった世界の整形外科手術市場規模が、2022年に430.4億ドルに到達し、2027年まで年平均6.30%で成長して585.2億ドルまで拡大すると予測しています。本レポートは、整形外科手術の世界市場について総合的・多面的に調査・分析し、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、手術別（美容における外科手術、やけどにおける外科手術、頭蓋顔面における外科手術、手における外科手術、その他）分析、製品別（注射剤、レーザー、脂肪吸引機器）分析、エンドユーザー別（外来手術センター、クリニック、病院、研究所・研究機関）分析、地域別（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）分析、競争状況、企業情報などを以下の構成でまとめております。本資料には、Aesthetic Solutions、Allergan plc、Alma Lasers、Alma Lasers, Ltd.、AQTIS Medical BV、B. Braun Melsungen AG、Bausch Health Companies Inc.などの企業情報が含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界の整形外科手術市場規模：手術別 - 美容外科における外科手術の市場規模 - やけどにおける外科手術の市場規模 - 頭蓋顔面における外科手術の市場規模 - 手における外科手術の市場規模 - その他の市場規模 ・世界の整形外科手術市場規模：製品別 - 整形外科手術用注射剤の市場規模 - 整形外科手術用レーザーの市場規模 - 整形外科手術用脂肪吸引機器の市場規模 ・世界の整形外科手術市場規模：エンドユーザー別 - 外来手術センターにおける市場規模 - クリニックにおける市場規模 - 病院における市場規模 - 研究所・研究機関における市場規模 ・世界の整形外科手術市場規模：地域別 - 南北アメリカの整形外科手術市場規模 アメリカの整形外科手術市場規模 カナダの整形外科手術市場規模 ブラジルの整形外科手術市場規模 … - アジア太平洋の整形外科手術市場規模 日本の整形外科手術市場規模 中国の整形外科手術市場規模 インドの整形外科手術市場規模 韓国の整形外科手術市場規模 台湾の整形外科手術市場規模 … - ヨーロッパ/中東/アフリカの整形外科手術市場規模 イギリスの整形外科手術市場規模 ドイツの整形外科手術市場規模 フランスの整形外科手術市場規模 ロシアの整形外科手術市場規模 … - その他地域の整形外科手術市場規模 ・競争状況 ・企業情報 |
The Global Plastic Surgery Market size was estimated at USD 40.56 billion in 2021 and expected to reach USD 43.04 billion in 2022, and is projected to grow at a CAGR 6.30% to reach USD 58.52 billion by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Plastic Surgery to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Surgery, the market was studied across Aesthetic Surgery, Burn Surgery, Craniofacial Surgery, Hand Surgery, Microsurgery, and Pediatric Plastic Surgery.
Based on Product, the market was studied across Injectable, Lasers, and Liposuction Equipment.
Based on End User, the market was studied across Ambulatory Surgical Centers, Clinics, Hospitals, and Research Laboratories & Institutes.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Plastic Surgery market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Plastic Surgery Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Plastic Surgery Market, including Aesthetic Solutions, Allergan plc, Alma Lasers, Alma Lasers, Ltd., AQTIS Medical BV, B. Braun Melsungen AG, Bausch Health Companies Inc., Cynosure, Evolus, Inc., Galderma S.A., Genesis Biosystems, Inc, Inmode Group, Integra LifeSciences Holdings Corporation, IRIDEX Corporation, Johnson & Johnson, Lumenis, Merz Pharma GmbH & Co. KGaA, Revance Therapeutics Inc., Sientra, Inc., Sinclair Pharma, Stryker Corporation, and Surgery Partners.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Plastic Surgery Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Plastic Surgery Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Plastic Surgery Market?
4. What is the competitive strategic window for opportunities in the Global Plastic Surgery Market?
5. What are the technology trends and regulatory frameworks in the Global Plastic Surgery Market?
6. What is the market share of the leading vendors in the Global Plastic Surgery Market?
7. What modes and strategic moves are considered suitable for entering the Global Plastic Surgery Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rise in the number of available certified service providers worldwide
5.1.1.2. Increasing consciousness among people about their aesthetic appearance and self-esteem
5.1.1.3. Surge in adoption of minimally invasive and non-invasive procedures
5.1.2. Restraints
5.1.2.1. Concerns over risks and complications during and post the surgery
5.1.3. Opportunities
5.1.3.1. Emerging technological developments in plastic surgery such as laser
5.1.3.2. Introduction of advanced materials such as silicone implants
5.1.4. Challenges
5.1.4.1. Strict regulatory approvals and dearth of expertise in the field
5.2. Cumulative Impact of COVID-19
6. Plastic Surgery Market, by Surgery
6.1. Introduction
6.2. Aesthetic Surgery
6.3. Burn Surgery
6.4. Craniofacial Surgery
6.5. Hand Surgery
6.6. Microsurgery
6.7. Pediatric Plastic Surgery
7. Plastic Surgery Market, by Product
7.1. Introduction
7.2. Injectable
7.3. Lasers
7.4. Liposuction Equipment
8. Plastic Surgery Market, by End User
8.1. Introduction
8.2. Ambulatory Surgical Centers
8.3. Clinics
8.4. Hospitals
8.5. Research Laboratories & Institutes
9. Americas Plastic Surgery Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Plastic Surgery Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Plastic Surgery Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis, By Key Player
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion
13. Company Usability Profiles
13.1. Aesthetic Solutions
13.1.1. Business Overview
13.1.2. Key Executives
13.1.3. Product & Services
13.2. Allergan plc
13.2.1. Business Overview
13.2.2. Key Executives
13.2.3. Product & Services
13.3. Alma Lasers
13.3.1. Business Overview
13.3.2. Key Executives
13.3.3. Product & Services
13.4. Alma Lasers, Ltd.
13.4.1. Business Overview
13.4.2. Key Executives
13.4.3. Product & Services
13.5. AQTIS Medical BV
13.5.1. Business Overview
13.5.2. Key Executives
13.5.3. Product & Services
13.6. B. Braun Melsungen AG
13.6.1. Business Overview
13.6.2. Key Executives
13.6.3. Product & Services
13.7. Bausch Health Companies Inc.
13.7.1. Business Overview
13.7.2. Key Executives
13.7.3. Product & Services
13.8. Cynosure
13.8.1. Business Overview
13.8.2. Key Executives
13.8.3. Product & Services
13.9. Evolus, Inc.
13.9.1. Business Overview
13.9.2. Key Executives
13.9.3. Product & Services
13.10. Galderma S.A.
13.10.1. Business Overview
13.10.2. Key Executives
13.10.3. Product & Services
13.11. Genesis Biosystems, Inc
13.11.1. Business Overview
13.11.2. Key Executives
13.11.3. Product & Services
13.12. Inmode Group
13.12.1. Business Overview
13.12.2. Key Executives
13.12.3. Product & Services
13.13. Integra LifeSciences Holdings Corporation
13.13.1. Business Overview
13.13.2. Key Executives
13.13.3. Product & Services
13.14. IRIDEX Corporation
13.14.1. Business Overview
13.14.2. Key Executives
13.14.3. Product & Services
13.15. Johnson & Johnson
13.15.1. Business Overview
13.15.2. Key Executives
13.15.3. Product & Services
13.16. Lumenis
13.16.1. Business Overview
13.16.2. Key Executives
13.16.3. Product & Services
13.17. Merz Pharma GmbH & Co. KGaA
13.17.1. Business Overview
13.17.2. Key Executives
13.17.3. Product & Services
13.18. Revance Therapeutics Inc.
13.18.1. Business Overview
13.18.2. Key Executives
13.18.3. Product & Services
13.19. Sientra, Inc.
13.19.1. Business Overview
13.19.2. Key Executives
13.19.3. Product & Services
13.20. Sinclair Pharma
13.20.1. Business Overview
13.20.2. Key Executives
13.20.3. Product & Services
13.21. Stryker Corporation
13.21.1. Business Overview
13.21.2. Key Executives
13.21.3. Product & Services
13.22. Surgery Partners
13.22.1. Business Overview
13.22.2. Key Executives
13.22.3. Product & Services
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing